Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.45, read 2026-10-27
Ethical passes the values gate
Price56.38 USD
Fair value39.81
Ethical score64.7/100
Our investment reviews on this name
2026-10-14Read Accumulation40.89+37.9% to today ✓Markdown gives way to Accumulation after a 9% rise in 12 days
2026-10-02Read Markdown37.60+49.9% to today Accumulation gives way to Markdown first Markdown read since July
2026-08-11Read Accumulation38.57+46.2% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-07-02Read Markdown39.10+44.2% to today First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Range Resources Corporation holds its Markup at $56.38. The statistical read favours the sellers, held for 368 days.
As held on the ledger · 2026-10-27
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 368 days
Price at the screen
$56.38
Valuation
11.94 trailing · 10.55 forward price to earnings
Values screen
PASS· score 64.7
Beta
0.71
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
18.49%
Below 33%
Interest-bearing debt is just 18.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
4.84%
Below 49%
Money owed to the company is 4.8% of assets, under the 49% limit.
Pass
Revenue purity
0.16%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Range Resources clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when RRC's ethical verdict changes
Today RRC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. The price runs 7.9% above the base estimate.
Third-party analyst targets: 24 covering, consensus Hold. The average target sits −20% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Appalachian gas wells hide a classic cyclical trap
Every winter price spike or LNG export boom sends more cash through Range Resources Appalachian wells. The numbers look solid with revenue up 26 percent, a 28 percent profit margin and 21 percent return on equity, all at a forward multiple of just 8.6 times. Current price sits 9 percent below our fair value estimate, yet the opportunity rating remains none.
This is the textbook cyclical value trap. Low multiples in energy often signal peak earnings rather than bargains, and the market is correctly treating the cycle as temporary. Twenty two analysts hold a neutral stance with a 44 dollar median target that already prices in some recovery.
Commodity swings and exploration risks sit at the heart of the downside. The ethical screen clears the business, but the cycle itself keeps any real edge out of reach. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
RRC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Accumulation$43.23+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 14% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$43.23+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 14% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$43.23+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$43.23+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$43.23+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$43.23+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$43.23+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$43.23+5.7%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47.
2026-10-02Markdown · changed$37.60-8.3%Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (22 analysts) rates it hold, with a mean price target of $47.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
